Equine Cushing's and Insulin Resistance Group Inc. Announces 2020 NO Laminitis! Conference

Laminitic horse hooves showing the growth of more toe and less heel
Laminitic horse hooves showing the growth of more toe and less heel VetMoves

Newsdate: Monday, 9, March 2020 – 8:30 am
Location: TEMPE, Arizona

The US alone has almost 10 million horses. The most current estimates are that 10% to 15% of horses will suffer from laminitis every year, with 80% to 90% of the cases caused by endocrine disease.

Horse with Cushing's disease.

Horse with Cushing's disease

Helping caregivers recognize the importance of diagnosis, diet, trim, and exercise has seen thousands of horses through the complications of Cushing's disease and insulin resistance.
© 2018 by Cheval-Ile-de-Batz

That is, on average, 1 million per year in the US alone. It can be a death sentence if not diagnosed and managed correctly.

Since 1999, the ECIR Group has improved the welfare of equines with metabolic disorder by focusing on prevention and treatment of endocrinopathic laminitis. Helping caregivers learn to recognize the importance of diagnosis, diet, trim, and exercise has seen thousands through the complications of Equine Cushing’s Disease and Insulin Resistance. To this end, the 2020 NO Laminitis! Conference planning is in the works. Details include these:

When: The weekend of October 24-26, 2020

Where: The Central Hotel and Conference Center, Harrisburg, PA

Speakers:

  • Eleanor M. Kellon, VMD
  • Robert M. Bowker, VMD, PhD
  • Kathleen Gustafson, PhD
  • Pete Ramey, PHCP Practitioner/Clinician
  • Paige Poss, APF, Anatomy of the Equine, LLC 
  • Elaine Norton, DVM, MS, PhD, DACVIM-LA
  • Shannon Pratt Phillips, MS, PhD, PAS

Topics:

  • EMS – What It's Not.
  • Protein and Iron. Their effect in EMS and PPID Horses.
  • Take it with a Grain of Salt – Navigating Nutritional Fact and Fiction.
  • The Effect of Exercise on Glucose Metabolism and Insulin Sensitivity in the Horse.
  • Strategies for Using Exercise as Part of Dietary Management for Over Weight and/or Insulin Resistant Horses.
  • Common EMS and PPID Pharmaceuticals.
  • Emerging EMS and PPID Pharmaceuticals. 
  • The Genetics of EMS.
  • The Impact of Genetics on Height and Insulin Dysregulation in Welsh Ponies.
  • Reading the Foot – Thinking Vertically.
  • Reversing Hoof Capsule Rotation and Distal Descent.
  • Looking Internally at Distal Descent and Rotation in the Hoof.
  • Estimating Palmar Angle When Looking at the Hoof.
  • What is a Normal foot? Questions Need to be Asked.
  • Trimming Practices Can Encourage Decline in Overall Foot Health.
  • Winter Laminitis: Why the Normal Trim Can Make an Episode Worse. 
  • How Trimming Can Improve Foot Structure and Function 

Attendees: Any professional or owner who has one or more horses in their care.

Ticket Pricing:

  • $300 Lecture Admission
  • $275 Early-bird (Registration prior to 09.16.20)
  • $115 Guest (Social functions only. No lecture)          

We will be applying for Veterinary and Hoof Professional Continuing Education Credit Hours and will announce that information when we receive approval.

As final details are put in place, registration info will be announced. Keep an eye out for conference info on groups.io, Facebook, ecirhorse.org, nolaminitis.org, and IVIS.

Attendees of the 2011, 2013, 2015, and 2017 conferences welcomed the latest in research and specific protocols used to improve the welfare of equines in their care. The 2020 NO Laminitis! Conference will continue to build on that mission.

About ECIR Group Inc

Started in 1999, the ECIR Group is the largest field-trial database for PPID and IR in the world and provides the latest research, diagnosis, and treatment information, in addition to dietary recommendations for horses with these conditions. Even universities do not and cannot compile and follow long term as many in-depth case histories of PPID/IR horses as the ECIR Group.

In 2013 the Equine Cushing's and Insulin Resistance Group Inc., an Arizona nonprofit corporation, was approved as a 501(c)3 public charity. Tax deductible contributions and grants support ongoing research, education, and awareness of Equine Cushing's Disease/PPID and Insulin Resistance.

THE MISSION of the ECIR Group Inc

. is to improve the welfare of equines with metabolic disorders via a unique interface between basic research and real-life clinical experience. Prevention of laminitis is the ultimate goal. The ECIR Group serves the scientific community, practicing clinicians, and owners by focusing on investigations most likely to quickly, immediately, and significantly benefit the welfare of the horse.


Press release provided by Nancy Collins - ECIR Group Inc

About the Author

Press Release

Author picture

This news article is a press release received by the organization or person noted above. Press releases from recognized horse health companies and individuals are frequently posted on EquiMed as a service to our visitors. Please contact the author of the press release directly for additional information.

Subscribe